Company Analysis Omega Healthcare Investors
1. Summary
Advantages
- Dividends (7.45%) are higher than the sector average (3.23%).
- The stock's return over the last year (18.72%) is higher than the sector average (-3.19%).
- The company's current efficiency (ROE=6.78%) is higher than the sector average (ROE=6.02%)
Disadvantages
- Price (36.84 $) is higher than fair price (10.12 $)
- Current debt level 55.58% has increased over 5 years from 1.28%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Omega Healthcare Investors | Real Estate | Index | |
|---|---|---|---|
| 7 days | 2.4% | -10.2% | 2.7% |
| 90 days | -5.1% | -12.8% | -4.5% |
| 1 year | 18.7% | -3.2% | 10% |
OHI vs Sector: Omega Healthcare Investors has outperformed the "Real Estate" sector by 21.91% over the past year.
OHI vs Market: Omega Healthcare Investors has outperformed the market by 8.68% over the past year.
Stable price: OHI is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: OHI with weekly volatility of 0.3601% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (36.84 $) is higher than the fair price (10.12 $).
Price is higher than fair: The current price (36.84 $) is 72.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (31.75) is lower than that of the sector as a whole (61.35).
P/E vs Market: The company's P/E (31.75) is lower than that of the market as a whole (73.05).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.04) is higher than that of the sector as a whole (-0.8993).
P/BV vs Market: The company's P/BV (2.04) is lower than that of the market as a whole (22.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (8.1) is higher than that of the sector as a whole (7.68).
P/S vs Market: The company's P/S indicator (8.1) is lower than that of the market as a whole (15.91).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (14.85) is lower than that of the sector as a whole (20.69).
EV/Ebitda vs Market: The company's EV/Ebitda (14.85) is lower than that of the market as a whole (23.05).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 10.41% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (10.41%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (12.56%).
5.4. ROE
ROE vs Sector: The company's ROE (6.78%) is higher than that of the sector as a whole (6.02%).
ROE vs Market: The company's ROE (6.78%) is lower than that of the market as a whole (25.12%).
5.5. ROA
ROA vs Sector: The company's ROA (2.66%) is lower than that of the sector as a whole (3.74%).
ROA vs Market: The company's ROA (2.66%) is lower than that of the market as a whole (6.65%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.18%) is higher than that of the sector as a whole (6.96%).
ROIC vs Market: The company's ROIC (7.18%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 7.45% is higher than the average for the sector '3.23%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 7.45% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 7.45% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (265.86%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
